Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.420
-0.030 (-2.07%)
Jun 8, 2026, 4:00 PM EDT - Market closed
Coherus Oncology Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 28, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $4 | Buy | Maintains | $4 | +181.69% | May 13, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $10 | Buy | Maintains | $10 | +604.23% | May 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 | Buy | Reiterates | $7 | +392.96% | May 12, 2026 |
| Guggenheim | Guggenheim | Buy Initiates $12 | Buy | Initiates | $12 | +745.07% | May 12, 2026 |